D. Silverman, N. Rothman, S. Devesa, K. Syrigos, and D. Skinner, Bladder Cancer, 1999.
DOI : 10.1093/acprof:oso/9780195149616.003.0058
URL : https://hal.archives-ouvertes.fr/hal-00697288

D. Parkin, S. Whelan, J. Ferlay, L. Leppo, and D. Thomas, Cancer incidence in five continents Lyon: IARC Publication, 2002.

M. Zeegers, F. Tan, E. Dorant, . Van-den, and P. Brandt, The impact of characteristics of cigarette smoking on urinary tract cancer risk, Cancer, vol.29, issue.3, pp.630-639, 2000.
DOI : 10.1002/1097-0142(20000801)89:3<630::AID-CNCR19>3.0.CO;2-Q

H. Herr, TUMOR PROGRESSION AND SURVIVAL OF PATIENTS WITH HIGH GRADE, NONINVASIVE PAPILLARY (TaG3) BLADDER TUMORS: 15-YEAR OUTCOME, The Journal of Urology, vol.163, issue.1, pp.60-62, 2000.
DOI : 10.1016/S0022-5347(05)67972-4

Z. Mao, M. Bozzella, A. Seluanov, and V. Gorbunova, DNA repair by nonhomologous end joining and homologous recombination during cell cycle in human cells, Cell Cycle, vol.7, issue.18, pp.2902-2906, 2008.
DOI : 10.4161/cc.7.18.6679

M. Christmann, M. Tomicic, W. Roos, and B. Kaina, Mechanisms of human DNA repair: an update, Toxicology, vol.193, issue.1-2, pp.3-34, 2003.
DOI : 10.1016/S0300-483X(03)00287-7

D. Zasimauskas and G. Zekonis, Effect of smoking on neutrophil oxidative metabolism, Medicina, vol.443, pp.195-200, 2008.

G. Xu, M. Herzig, V. Rotrekl, and C. Walter, Base excision repair, aging and health span, Mechanisms of Ageing and Development, vol.129, issue.7-8, pp.366-382, 2008.
DOI : 10.1016/j.mad.2008.03.001

J. Lin, G. Swan, P. Shields, N. Benowitz, J. Gu et al., Mutagen Sensitivity and Genetic Variants in Nucleotide Excision Repair Pathway: Genotype-Phenotype Correlation, Cancer Epidemiology Biomarkers & Prevention, vol.16, issue.10, pp.2065-2071, 2007.
DOI : 10.1158/1055-9965.EPI-06-1041

S. Gowda, M. Kumaran, B. Suma, and M. Rao, Single nucleotide polymorphism analysis of the nucleotide-excision repair genes XPC, XPA, and XPG in the Indian population, Hum Biol, vol.79, pp.545-562, 2007.

J. Egly, TFIIH: from transcription to clinic, FEBS Letters, vol.26, issue.2-3, pp.124-128, 2001.
DOI : 10.1016/S0014-5793(01)02458-9

Z. Chen, Y. J. Wang, G. Song, B. Li, J. Xu et al., Attenuated Expression of Xeroderma Pigmentosum Group C Is Associated with Critical Events in Human Bladder Cancer Carcinogenesis and Progression, Cancer Research, vol.67, issue.10, pp.4578-4585, 2007.
DOI : 10.1158/0008-5472.CAN-06-0877

M. Shen, R. Hung, P. Brennan, C. Malaveille, F. Donato et al., Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy, Cancer Epidemiol Biomarkers Prev, vol.12, pp.1234-1240, 2003.

M. García-closas, N. Malats, F. Real, R. Welch, M. Kogevinas et al., Genetic Variation in the Nucleotide Excision Repair Pathway and Bladder Cancer Risk, Cancer Epidemiology Biomarkers & Prevention, vol.15, issue.3, pp.536-542, 2006.
DOI : 10.1158/1055-9965.EPI-05-0749

S. Sanyal, F. Festa, S. Sakano, Z. Zhang, G. Steineck et al., Polymorphisms in DNA repair and metabolic genes in bladder cancer, Carcinogenesis, vol.25, issue.5, pp.729-734, 2004.
DOI : 10.1093/carcin/bgh058

W. Gao, M. Romkes, S. Zhong, T. Nukui, R. Persad et al., Genetic polymorphisms in the DNA repair genes XPD and XRCC1, p53 gene mutations and bladder cancer risk, Oncol Rep, vol.24, issue.1, pp.257-262, 2010.

C. Li, Z. Jiang, and X. Liu, XPD Lys751Gln and Asp312Asn polymorphisms and bladder cancer risk: a meta-analysis, Molecular Biology Reports, vol.72, issue.1, pp.301-309, 2010.
DOI : 10.1007/s11033-009-9693-1

J. Sambrook, E. Fritsch, and T. Maniatis, Molecular cloning: a laboratory manual. 2 edition, 1989.

G. Matullo, S. Guarrera, S. Carturan, M. Peluso, C. Malaveille et al., DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study, International Journal of Cancer, vol.9, issue.4, pp.562-567, 2001.
DOI : 10.1002/ijc.1228

L. Excoffier, G. Laval, and S. Schneider, Arlequin (version 3.0): An integrated software package for population genetics data analysis, Evol Bioinform Online, vol.1, pp.47-50, 2005.

Z. Feng, W. Hu, W. Rom, F. Beland, and M. Tang, 4-Aminobiphenyl is a major etiological agent of human bladder cancer: evidence from its DNA binding spectrum in human p53 gene, Carcinogenesis, vol.23, issue.10, pp.1721-1727, 2002.
DOI : 10.1093/carcin/23.10.1721

S. Ouerhani, K. Rouissi, N. Kourda, R. Marrakchi, K. Bougatef et al., Combined Analysis of Smoking, TP53, and FGFR3 Mutations in Tunisian Patients with Invasive and Superficial High-Grade Bladder Tumors, Cancer Investigation, issue.10, pp.27998-1007, 2009.
DOI : 10.1080/07357900902849707

I. Thompson, M. Peek, and F. Rodriguez, The impact of cigarette smoking on stage, grade and number of recurrences of transitional cell carcinoma of the bladder, J Urol, vol.137, issue.3, pp.401-403, 1987.

E. Goode, C. Ulrich, and J. Potter, Polymorphisms in DNA repair genes and associations with cancer risk, Cancer Epidemiol Biomarkers Prev, vol.11, pp.1513-1530, 2002.

L. Mechanic, R. Millikan, J. Player, A. De-cotret, S. Winkel et al., Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case-control study, Carcinogenesis, vol.27, issue.7, pp.271377-1385, 2006.
DOI : 10.1093/carcin/bgi330

I. Agalliu, E. Kwon, C. Salinas, J. Koopmeiners, E. Ostrander et al., Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study, Cancer Causes & Control, vol.97, issue.17, pp.289-300, 2010.
DOI : 10.1007/s10552-009-9461-5

P. De-verdier, S. Sanyal, J. Bermejo, G. Steineck, K. Hemminki et al., Genotypes, haplotypes and diplotypes of three XPC polymorphisms in urinary-bladder cancer patients, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol.694, issue.1-2, pp.39-44, 2010.
DOI : 10.1016/j.mrfmmm.2010.09.003

M. Stern, J. Lin, J. Figueroa, K. Kelsey, A. Kiltie et al., Polymorphisms in DNA Repair Genes, Smoking, and Bladder Cancer Risk: Findings from the International Consortium of Bladder Cancer, Cancer Research, vol.69, issue.17, pp.696857-6864, 2009.
DOI : 10.1158/0008-5472.CAN-09-1091

S. Sak, J. Barrett, A. Paul, D. Bishop, and A. Kiltie, The polyAT, intronic IVS11-6 and Lys939Gln XPC polymorphisms are not associated with transitional cell carcinoma of the bladder, British Journal of Cancer, vol.61, issue.12, pp.922262-2265, 2005.
DOI : 10.1002/1097-0142(20000801)89:3<630::AID-CNCR19>3.3.CO;2-H

R. Gangwar, D. Ahirwar, A. Mandhani, and R. Mittal, Influence of XPD and APE1 DNA Repair Gene Polymorphism on Bladder Cancer Susceptibility in North India, Urology, vol.73, issue.3, pp.675-680, 2009.
DOI : 10.1016/j.urology.2008.09.043

F. Coin, E. Bergmann, A. Tremeau-bravard, and J. Egly, Mutations in XPB and XPD helicases found in xeroderma pigmentosum patients impair the transcription function of TFIIH, The EMBO Journal, vol.18, issue.5, pp.1357-1366, 1999.
DOI : 10.1093/emboj/18.5.1357

T. Soussi and C. Béroud, Assessing TP53 status in human tumours to evaluate clinical outcome, Nature Reviews Cancer, vol.1, issue.3, pp.233-240, 2001.
DOI : 10.1038/35106009

S. Sakano, R. Kumar, P. Larsson, E. Onelöv, J. Adolfsson et al., A single-nucleotide polymorphism in the XPG gene, and tumour stage, grade, and clinical course in patients with nonmuscle-invasive neoplasms of the urinary bladder, BJU International, vol.400, issue.4, pp.847-851, 2006.
DOI : 10.1111/j.1464-410X.2004.04929.x

. Rouissi, The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development, BMC Cancer, vol.97, issue.4, pp.11-101, 2011.
DOI : 10.1111/j.1464-410X.2005.05994.x
URL : https://hal.archives-ouvertes.fr/pasteur-00606720